Strategic Partners

For more than 50 years, NFID has been a leader and innovator in addressing challenges and minimizing the impact of infectious diseases on US public health. NFID has educated and engaged millions, from families with small children to experienced healthcare professionals to community leaders and policymakers.

The NFID Strategic Partners Program enables organizations to join a pivotal group of leaders in the field of infectious diseases, offering opportunites for  access, awareness, and advancement. To learn more, contact info@nfid.org.

 

---

2025 Strategic Partners

Diamond:

• AstraZeneca
• Bavarian Nordic, Inc.
• GSK
• ModernaTX, Inc.
• Pfizer Inc.
• Sanofi US

Platinum:

• Novavax, Inc.

Gold:

• CSL Seqirus
• Merck & Co., Inc.